BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7046389)

  • 1. Metabolism and toxicity of aflatoxins.
    Hsieh DP; Wong JJ
    Adv Exp Med Biol; 1981; 136 Pt B():847-63. PubMed ID: 7046389
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of phenobarbital pretreatment on the metabolism and toxicokinetics of aflatoxin B1 in the rhesus monkey.
    Wong ZA; Wei CI; Rice DW; Hsieh DP
    Toxicol Appl Pharmacol; 1981 Sep; 60(3):387-97. PubMed ID: 6794183
    [No Abstract]   [Full Text] [Related]  

  • 3. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation of aflatoxins related to their mutagenicity.
    Gurtoo HL; Dahms RP; Paigen B
    Biochem Biophys Res Commun; 1978 Apr; 81(3):965-72. PubMed ID: 352354
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530.
    Garner RC; Miller EC; Miller JA
    Cancer Res; 1972 Oct; 32(10):2058-66. PubMed ID: 4404160
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative aflatoxin B1 mutagenesis of Salmonella typhimurium TA 100 in metabolic and photoactivation systems.
    Israel-Kalinsky H; Malca-Mor L; Stark AA
    Cancer Res; 1984 May; 44(5):1831-9. PubMed ID: 6424931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between vitamin A dietary intake and mutagenic activity of some chemical carcinogens.
    Cassand P; Leveque F; Decoudu S; Narbonne JF
    Food Addit Contam; 1990; 7 Suppl 1():S58-9. PubMed ID: 2124552
    [No Abstract]   [Full Text] [Related]  

  • 8. The activation of aflatoxin B1 in liver slices and in bacterial mutagenicity assays using livers from different species including man.
    Booth SC; Bösenberg H; Garner RC; Hertzog PJ; Norpoth K
    Carcinogenesis; 1981; 2(10):1063-8. PubMed ID: 6794925
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1.
    Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O
    J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rapid method of indicating fungal toxins possessing genetic activity].
    Vasil'ev OD
    Tr Inst Im Pastera; 1982; 57():74-7. PubMed ID: 6763385
    [No Abstract]   [Full Text] [Related]  

  • 11. The direct mutagenicity of aflatoxin B1 and metabolites to Salmonella typhimurium: structure mutagenicity relationships and mechanisms of action.
    Yourtee DM; Kirk-Yourtee CL; Searles S
    Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):55-76. PubMed ID: 3118438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclophosphamide mutagenicity by beta-carotene.
    Belisario MA; Pecce R; Battista C; Panza N; Pacilio G
    Biomed Pharmacother; 1985; 39(8):445-8. PubMed ID: 3914914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of substrates and inhibitors of monoamine oxidase on hepatic dimethylnitrosamine metabolism and mutagenicity.
    Lake BG; Rowland IR; Harris RA; Collins MA; Phillips JC; Cottrell RC; Gangolli SD
    Adv Exp Med Biol; 1981; 136 Pt B():1143-7. PubMed ID: 6283820
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of lysis in lysogenic bacteria by liver microsomal metabolites of aflatoxin B1.
    Buch JK; Dave PJ
    Indian J Exp Biol; 1980 Oct; 18(10):1162-4. PubMed ID: 6783510
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of lactone ring of aflatoxin B1 in toxicity and mutagenicity.
    Lee LS; Dunn JJ; DeLucca AJ; Ciegler A
    Experientia; 1981 Jan; 37(1):16-7. PubMed ID: 6781926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by specific antibodies of the mutagenicity of aflatoxin B1 in bacteria.
    Sizaret P; Malaveille C; Brun G; Aguelon AM; Toussaint G
    Oncodev Biol Med; 1982; 3(2-3):125-34. PubMed ID: 6812028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of 2-acetylaminofluorene.
    Thorgeirsson SS; Wirth PJ; Staiano N; Smith CL
    Adv Exp Med Biol; 1981; 136 Pt B():897-919. PubMed ID: 7046390
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcinogenesis by fungal products.
    Garner RC
    Br Med Bull; 1980 Jan; 36(1):47-52. PubMed ID: 7020829
    [No Abstract]   [Full Text] [Related]  

  • 19. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical mutagenicity and cellular status in vitamins A, E and C.
    Narbonne JF; Cassand P; Daubeze M; Colin C; Leveque F
    Food Addit Contam; 1990; 7 Suppl 1():S48-52. PubMed ID: 2124551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.